OrthoPulse 2.0 and 2.1 Feasibility Evaluation
- Conditions
- Malocclusion
- Interventions
- Device: OrthoPulse 2.0Device: OrthoPulse 2.1Device: Fixed Orthodontic Appliances (Braces)Device: Invisalign 3.5 Day Wear
- Registration Number
- NCT03683017
- Lead Sponsor
- Biolux Research Holdings, Inc.
- Brief Summary
OrthoPulse is a device that uses near-infrared light therapy in order to decrease orthodontic treatment time. The aim of this study is to evaluate OrthoPulse products modified with extended arrays, OrthoPulse 2.0 and OrthoPulse 2.1, and to assess their clinical effectiveness.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 35
- Written Informed Consent must be obtained before any assessment is performed
- Patient must be 11 years of age or older; minors will only be included in the study with the consent of the Parent/Legal Authorized Representative (LAR)
- Presence of permanent dentition
- Eligible and scheduled for full mouth fixed orthodontic treatment or Invisalign
- Good oral hygiene
- Likely to be compliant to OrthoPulse 2.0 and 2.1 use, aligner wear and elastic wear
- Have a compatible iOS or Android device and are willing to download the OrthoPulse app for frequent automatic syncing of use data
- Patient is currently enrolled in another clinical study
- Periodontally involved teeth, acute oral infection or periodontal disease
- Use of bisphosphonates (osteoporosis drugs) during the study
- Use of drugs that may cause photosensitivity
- History of photosensitivity
- History of poor oral hygiene, per the discretion of the Principal Investigator (PI)
- Epilepsy
- Patient plans to relocate over the treatment period
- Smoker or use of any tobacco containing products per the discretion of the PI
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description I-OP2.0 OrthoPulse 2.0 Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device. F-OP2.0 Fixed Orthodontic Appliances (Braces) Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device. I-OP2.1 OrthoPulse 2.1 Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.1 device. I-OP2.0 Invisalign 3.5 Day Wear Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device. I-OP2.1 Invisalign 3.5 Day Wear Patients receive Invisalign orthodontic treatment, with 3.5 day Aligner changes, by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.1 device. F-OP2.0 OrthoPulse 2.0 Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Patients receive OrthoPulse 2.0 device.
- Primary Outcome Measures
Name Time Method Feedback on general experience Through Study Completion, approx. 2 years Assess doctor and patient feedback on the general experience with OrthoPulse 2.0 and OrthoPulse 2.1 as measured in the electronic data capture system.
Feedback on clinical performance Through Study Completion, approx. 2 years Assess doctor subjective and objective feedback on the clinical performance of OrthoPulse 2.0 and OrthoPulse 2.1 as measured in the electronic data capture system.
Adverse events Through Study Completion, approx. 2 years Confirm initial safety of OrthoPulse 2.0 and OrthoPulse 2.1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Bella Smile
🇺🇸San Francisco, California, United States
Dickerson Orthodontics
🇺🇸Scottsdale, Arizona, United States
Sphinx Orthodontics
🇨🇦Edmonton, Alberta, Canada
Chenin Orthodontics
🇺🇸Henderson, Nevada, United States